Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gut-specific Neprilysin Deletion Protects Against Fat-induced Insulin Secretory Dysfunction in Male Mice. | Endocrinology | 2024 | 38953181 | PubTator, text mining | PubMed |
| Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses. | Front Pharmacol | 2024 | 38948469 | PubTator, text mining | PubMed |
| Dissecting Crucial Gene Markers Involved in HPV-Associated Oropharyngeal Squamous Cell Carcinoma from RNA-Sequencing Data through Explainable Artificial Intelligence. | Front Biosci (Landmark Ed) | 2024 | 38940026 | PubTator, text mining | PubMed |
| Half of most frequently mutated genes in breast cancer are expressed differentially between premenopausal and postmenopausal breast cancer patients. | Cancer Genet | 2024 | 38879914 | PubTator, text mining | PubMed |
| Pan-cancer analysis predict that FAT1 is a therapeutic target and immunotherapy biomarker for multiple cancer types including non-small cell lung cancer. | Front Immunol | 2024 | 38855103 | PubTator, text mining | PubMed |
| The tumor suppressor Fat1 is dispensable for normal murine hematopoiesis. | J Leukoc Biol | 2024 | 38833591 | PubTator, text mining | PubMed |
| Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma. | Cancer Immunol Immunother | 2024 | 38832974 | PubTator, text mining | PubMed |
| Metabolic Contrasts: Fatty Acid Oxidation and Ketone Bodies in Healthy Brains vs. Glioblastoma Multiforme. | Int J Mol Sci | 2024 | 38791520 | PubTator, text mining | PubMed |
| FAT1 inhibits the proliferation of DLBCL cells via increasing the m6A modification of YAP1 mRNA. | Sci Rep | 2024 | 38782965 | PubTator, text mining | PubMed |
| Genome-wide characterization of the mutational landscape of proliferative verrucous leukoplakia. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2024 | 38760284 | PubTator, text mining | PubMed |
| Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study. | Int J Surg | 2024 | 38742845 | PubTator, text mining | PubMed |
| The immune response-related genomic alterations in patients with malignant melanoma. | Medicine (Baltimore) | 2024 | 38669390 | PubTator, text mining | PubMed |
| TITAN: Combining a bidirectional forwarding graph and GCN to detect saturation attack targeted at SDN. | PLoS One | 2024 | 38669264 | PubTator, text mining | PubMed |
| CWGCNA: an R package to perform causal inference from the WGCNA framework. | NAR Genom Bioinform | 2024 | 38666214 | PubTator, text mining | PubMed |
| Editorial: Non-cadherin based cell adhesion in tissue remodeling. | Front Cell Dev Biol | 2024 | 38665429 | PubTator, text mining | PubMed |
| STAT1 mediated downregulation of the tumor suppressor gene PDCD4, is driven by the atypical cadherin FAT1, in glioblastoma. | Cell Signal | 2024 | 38640981 | PubTator, text mining | PubMed |
| Crossing the Andes: Challenges and opportunities for digital pathology in Latin America. | J Pathol Inform | 2024 | 38638195 | PubTator, text mining | PubMed |
| Contributions of the Dachsous intracellular domain to Dachsous-Fat signaling. | bioRxiv | 2024 | 38617303 | PubTator, text mining | PubMed |
| Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal Cancer. | Int J Mol Sci | 2024 | 38612819 | PubTator, text mining | PubMed |
| Diagnostic Challenges and Emerging Pathogeneses of Selected Glomerulopathies. | Pediatr Dev Pathol | 2024 | 38576387 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=18